Evaluating risk factors for acute graft versus host disease in pediatric hematopoietic stem cell transplant patients receiving tacrolimus

Evaluating risk factors for acute graft versus host disease in pediatric hematopoietic stem cell transplant patients receiving tacrolimus

Abstract To identify the clinical and pharmacological risk factors associated with tacrolimus pharmacodynamics for acute graft‐versus‐host disease (aGVHD) in pediatric patients receiving allogeneic hematopoietic stem cell transplantation (HSCT) from a matched related donor. A retrospective cohort si...

Full description

Bibliographic Details
Main Authors:	Michael Phan, Rishikesh Chavan, Richard Beuttler, Nicole Benipayo, Grace Magedman, David Buchbinder, Daniel Tomaszewski, Sun Yang
Format:	Article
Language:	English
Published:	Wiley 2021-07-01
Series:	Clinical and Translational Science
Online Access:	https://doi.org/10.1111/cts.12982

Similar Items

Graft versus host disease in a patient with chronic granulocytic leukemia who received an hematopoietic progenitor cell transplant
by: Marta Zapata-Tarrés, et al.
Published: (2014-07-01)

Effect of Early Post-Transplantation Tacrolimus Concentration on the Risk of Acute Graft-Versus-Host Disease in Allogenic Stem Cell Transplantation
by: Nidhi Sharma, et al.
Published: (2021-02-01)

Conjunctival Acute Graft-versus-Host Disease in Adult Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation: A Cohort Study.
by: Yao-Chung Liu, et al.
Published: (2016-01-01)

Graft-versus-host disease after allogeneic hematopoietic stem cell transplantation in children
by: Y. V. Skvortsova, et al.
Published: (2016-12-01)

Acute and chronic Graft-versus-host disease after hematopoietic stem cell transplantation
by: Vaneuza A. M. Funke, et al.

Scabies mimicking graft versus host disease in a hematopoietic cell transplant recipient
by: Dongsub Kim, et al.
Published: (2018-11-01)

Biomarkers in graft versus host disease after allogeneic hematopoietic stem cell transplant
by: Geary, Joshua J.
Published: (2016)

Evaluation of risk for graft-versus-host disease in children who receive less than the full doses of mini-dose methotrexate for graft-versus-host disease prophylaxis in allogeneic hematopoietic stem cell transplantation
by: Sook Kyung Yum, et al.
Published: (2013-11-01)

Immune reconstitution and graft-versus-host reactions in rat models of allogeneic hematopoietic cell transplantation
by: Severin eZinöcker, et al.
Published: (2012-11-01)

Natural Killer Cells in Graft-versus-Host-Disease after Allogeneic Hematopoietic Cell Transplantation
by: Robert S. Negrin, et al.
Published: (2017-04-01)

Methotrexate for the Treatment of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
by: Amr Nassar, et al.
Published: (2014-01-01)

Prediction of absolute risk of acute graft-versus-host disease following hematopoietic cell transplantation.
by: Catherine Lee, et al.
Published: (2018-01-01)

Vitamin D deficiency and graft-versus-host disease in hematopoietic stem cell transplant population
by: Abeer Arain, et al.
Published: (2019-09-01)

Gastrointestinal tract and liver graft-versus-host disease in pediatric patients with hematopoietic progenitor cell transplantation at a tertiary care center in Mexico
by: C.M. Jaramillo-Esparza, et al.
Published: (2018-10-01)

Dermoscopy of Cutaneous Graft-Versus-Host-Disease in Patients After Allogeneic Hematopoietic Stem Cell Transplantation
by: Grażyna Kaminska-Winciorek, et al.
Published: (2020-07-01)

Muscle cramps and neuropathies in patients with allogeneic hematopoietic stem cell transplantation and graft-versus-host disease.
by: Peter D Kraus, et al.
Published: (2012-01-01)

Helper Innate Lymphoid Cells in Allogenic Hematopoietic Stem Cell Transplantation and Graft Versus Host Disease
by: Linda Quatrini, et al.
Published: (2020-09-01)

NURSING DIAGNOSES AND INTERVENTIONS FOR PATIENTS WITH GRAFT-VERSUS-HOST DISEASE SUBMITTED TO HEMATOPOIETIC STEM CELL TRANSPLANTATION
by: Diogo Dias Araujo, et al.
Published: (2015-06-01)

Topical tacrolimus for refractory superficial mucoceles in a patient with chronic graft versus host disease
by: Alana Deutsch, BA, et al.
Published: (2020-05-01)

Therapeutic monitoring of pediatric transplant patients with conversion to generic tacrolimus
by: Natalia Riva, et al.
Published: (2017-03-01)

Cytokine Profiles in Various Graft-Versus-Host Disease Target Organs following Hematopoietic Stem Cell Transplantation
by: Hsiu-Yu Lai, et al.
Published: (2012-09-01)

The role of mesenchymal stem cells in hematopoietic stem cell transplantation: prevention and treatment of graft-versus-host disease
by: Lu Zhao, et al.
Published: (2019-06-01)

“Age Related Differences in the Biology of Chronic Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation”
by: Geoff D. E. Cuvelier, et al.
Published: (2020-10-01)

Quality of life of patients with graft-versus-host disease (GvHD) post-hematopoietic stem cell transplantation
by: Sibéli de Fátima Ferraz Simão Proença, et al.

Characteristics and risk of chronic graft-versus-host disease of liver in allogeneic hematopoietic stem cell transplant recipients.
by: Chien-Ting Chen, et al.
Published: (2017-01-01)

Selective targeting of histone modification fails to prevent graft versus host disease after hematopoietic cell transplantation.
by: Bader Alahmari, et al.
Published: (2018-01-01)

Invariant Natural Killer T Cells As Suppressors of Graft-versus-Host Disease in Allogeneic Hematopoietic Stem Cell Transplantation
by: Melissa Mavers, et al.
Published: (2017-07-01)

HMG-CoA reductase inhibitors in kidney transplant recipients receiving tacrolimus: statins not associated with improved patient or graft survival
by: Schaefer Heidi, et al.
Published: (2010-04-01)

Graft and survival outcome in renal transplant patients receiving cyclosporine and azathioprine versus tacrolimus and mycophenolate mofetil: A single-center retrospective observational study
by: Renuka Sathish, et al.
Published: (2021-01-01)

A prospective study of correlation of blood levels of tacrolimus to graft function and adverse effect of tacrolimus in postrenal transplant patients
by: Krishna Asuri, et al.
Published: (2020-01-01)

Possible implication of bacterial infection in acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
by: Shigeo eFuji, et al.
Published: (2014-04-01)

Correction: Characteristics and risk of chronic graft-versus-host disease of liver in allogeneic hematopoietic stem cell transplant recipients.
by: Chien-Ting Chen, et al.
Published: (2018-01-01)

Targeting T-bet for Prevention of Graft-Versus-Host Disease and Leukemia Relapse after Allogeneic Hematopoietic Stem Cell Transplantation
by: Fu, Jianing
Published: (2015)

Pediatric Hematopoietic Stem Cell Transplantation
by: Gaurav Kharya, et al.
Published: (2015-01-01)

Pediatric Hematopoietic Stem Cell Transplantation
by: Amir Ali Hamidieh
Published: (2014-05-01)

Influence of Germline Genetics on Tacrolimus Pharmacokinetics and Pharmacodynamics in Allogeneic Hematopoietic Stem Cell Transplant Patients
by: Jing Zhu, et al.
Published: (2020-01-01)

Metabolic Targets for Improvement of Allogeneic Hematopoietic Stem Cell Transplantation and Graft-vs.-Host Disease
by: Natalia M. Tijaro-Ovalle, et al.
Published: (2019-03-01)

Grait versus host disease in a patient with chornic granulocytic leukemia who received an hematopoietic progenitor cell transplant
by: Zapata Tarrés Marta, et al.
Published: (2014-07-01)

Evaluating the Impact of CYP3A5 Genotype on Post-Transplant Healthcare Resource Utilization in Pediatric Renal and Heart Transplant Recipients Receiving Tacrolimus
by: Pasternak AL, et al.
Published: (2021-03-01)

Monitoring the Intracellular Tacrolimus Concentration in Kidney Transplant Recipients with Stable Graft Function.
by: Seung Seok Han, et al.
Published: (2016-01-01)

Cannot write session to /tmp/vufind_sessions/sess_44uqciu1ji16pd51cuo2ger6p6